Stanford University
Showing 121-128 of 128 Results
-
Kate Bubar
Postdoctoral Scholar, Infectious Diseases
BioKate is a postdoc in the Lo Lab. With a background in applied mathematics, statistics, and infectious disease epidemiology, she is passionate about using data-driven models to better understand infectious disease dynamics with the ultimate goal of informing public health policies and reducing disease burden.
-
Jessica Kopcho Buesing, MD
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioDr. Jessica Buesing is a board-certified internal medicine physician dedicated to providing empathic, honest, open, and compassionate patient care. Before joining Menlo Medical, she cared for veterans as an academic hospitalist at the Palo Alto VA for two years. Her professional interests include improving health span and quality of life, chronic disease prevention and management, comprehensive cancer survivorship care, improving health disparities, mental health support and addiction treatment. She is committed to personalized medicine and emphasizes shared decision-making, recognizing that effective healthcare must be tailored to each patient’s unique needs. Outside of work she enjoys camping, exercise, playing music, and spending time with her husband, two children, and cats.
-
Nam Quoc Bui
Clinical Associate Professor, Medicine - Oncology
BioDr. Bui is a Clinical Associate Professor of Medicine at the Stanford Cancer Institute and a specialist in Sarcoma. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data.
He is involved in numerous sarcoma clinical trials, leading efforts to take new therapeutics from the lab to clinical practice. His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies. He also is involved in education at the Stanford University School of Medicine, serving as a lecturer and mentor to medical students, residents, and oncology fellows. Dr. Bui is the founding Editor-in-Chief of the journal “Current Problems in Cancer: Case Reports”, an international, peer-reviewed journal that publishes groundbreaking cases that give insight into redefining concepts in cancer. He also serves as the Chair of the Data Safety Monitoring Committee at the Stanford Cancer Institute, overseeing the board that reviews all investigator-initiated cancer trials run at Stanford. -
Jeffrey Bunker
Fellow in Medicine - Med/Infectious Diseases
BioJeffrey Bunker is an infectious diseases physician-scientist, immunologist, and microbiologist. He is currently a clinical fellow in infectious diseases at Stanford University; he previously completed residency training in internal medicine at Stanford University and an M.D. and Ph.D. in immunology at the University of Chicago. Bunker’s research investigates interactions between the microbiome and the immune system, including fundamental questions about how and why certain microbes generate immune responses and how this interplay influences both normal homeostasis and infectious or inflammatory diseases. His clinical interests include microbial pathogenesis, antimicrobial resistance, and the diagnosis and treatment of complex infections.
-
Stephan Busque
Professor of Surgery (Abdominal Transplantation), and by courtesy, of Medicine (Nephrology)
On Partial Leave from 04/13/2026 To 06/26/2026Current Research and Scholarly InterestsMy research interest is focused on the improvement of clinical immunosuppression. I am involved in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic. My ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am an investigator part of a multidisciplinary tolerance induction project using total lymphoid irradiation and donor hematopoietic stem cells infusion after living donor kidney transplantation.
